Karp Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-74,930
Closed -$12.1M 141
2021
Q4
$12.1M Buy
74,930
+9,779
+15% +$1.58M 1.52% 22
2021
Q3
$10.8M Buy
+65,151
New +$11.1M 1.53% 18
2021
Q2
Sell
-53,795
Closed -$8.63M 168
2021
Q1
$8.63M Buy
53,795
+3,830
+8% +$656K 1.56% 22
2020
Q4
$8.39M Buy
49,965
+360
+0.7% +$58.4K 1.73% 21
2020
Q3
$7.8M Buy
49,605
+4,455
+10% +$728K 1.91% 21
2020
Q2
$7.58M Buy
45,150
+2,654
+6% +$417K 2.1% 16
2020
Q1
$5.57M Buy
42,496
+4,446
+12% +$633K 1.83% 18
2019
Q4
$5.66M Buy
38,050
+1,355
+4% +$186K 1.49% 28
2019
Q3
$4.54M Buy
36,695
+11,115
+43% +$1.48M 1.32% 33
2019
Q2
$3.6M Buy
25,580
+23,145
+951% +$3.19M 1.14% 39
2019
Q1
$367K Buy
2,435
+170
+8% +$24.5K 0.13% 95
2018
Q4
$281K Sell
2,265
-370
-14% -$50.6K 0.13% 90
2018
Q3
$418K Buy
2,635
+20
+0.8% +$3.03K 0.14% 102
2018
Q2
$366K Buy
+2,615
New +$359K 0.14% 102

Other funds holding FBT

Karp Capital Management's FBT Position: Q1 2022 in Review

Karp Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2022, closing a stake of 74,930 shares — an estimated $12.1M sold.

Karp Capital Management first reported a position in FBT in Q2 2018 and held it in 14 quarters. The position peaked at $12.1M in Q4 2021. 220 funds tracked by Wall St. Rank hold FBT as of Q1 2022.

  • Karp Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2022 after selling out during the quarter.
  • Karp Capital Management sold 74,930 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2022, an estimated $12.1M.
  • Karp Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2018 and held it in 14 quarters.
  • Karp Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $12.1M in Q4 2021.
  • 220 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2022.

Based on Karp Capital Management's 13F filing for Q1 2022, filed 11 Apr 2022.